For research use only. Not for therapeutic Use.
Irbesartan(Cat No.:A000217)is an angiotensin II receptor blocker (ARB) used to treat hypertension and manage kidney disease in patients with type 2 diabetes. It works by blocking the effects of angiotensin II, a hormone that constricts blood vessels, thus helping to lower blood pressure and improve blood flow. Irbesartan is effective in reducing the risk of stroke, heart attack, and progression of diabetic nephropathy. Its once-daily dosing and favorable side effect profile make it a commonly prescribed option for long-term cardiovascular and renal protection.
CAS Number | 138402-11-6 |
Synonyms | 138402-11-6; Aprovel; Avapro; Karvea; SR-47436 |
Molecular Formula | C25H28N6O |
Purity | ≥95% |
Target | Apoptosis |
Solubility | >17.4mg/mL in DMSO |
Storage | -20°C |
IUPAC Name | 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one |
InChI | InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30) |
InChIKey | YOSHYTLCDANDAN-UHFFFAOYSA-N |
SMILES | CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 |
Reference | 1: Suryadevara V, Lankapalli SR, Danda LH, Pendyala V, Katta V. Studies on 2: Yamabe H, Kaikita K, Matsumura T, Iwasa A, Koyama J, Uemura T, Morikami Y, <br> 4: Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei 5: Ye XL, Huang WC, Zheng YT, Liang Y, Gong WQ, Yang CM, Liu B. [Irbesartan <br> 7: Li S, Wang K, Xu G, Ji J, Qin C. The intervention effect of zinc 8: Liossi ΑS, Ntountaniotis D, Kellici TF, Chatziathanasiadou MV, Megariotis G, <br> 10: Yousif NG, Hadi NR, Al-Amran F, Zigam QA. Cardioprotective effects of |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |